Cellectar Biosciences Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option

By: via Benzinga
Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.